| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Galectins | 35 | 2023 | 278 | 12.870 |
Why?
|
| Erythrocyte Transfusion | 46 | 2024 | 551 | 9.790 |
Why?
|
| Isoantibodies | 42 | 2024 | 638 | 7.760 |
Why?
|
| Erythrocytes | 47 | 2024 | 2397 | 6.940 |
Why?
|
| Anemia, Sickle Cell | 20 | 2024 | 1033 | 5.430 |
Why?
|
| Isoantigens | 15 | 2023 | 496 | 5.190 |
Why?
|
| Polysaccharides | 24 | 2023 | 1006 | 4.410 |
Why?
|
| Galectin 1 | 20 | 2022 | 127 | 4.280 |
Why?
|
| Hemolysis | 12 | 2024 | 419 | 3.580 |
Why?
|
| Blood Group Antigens | 8 | 2024 | 188 | 3.300 |
Why?
|
| Blood Group Incompatibility | 13 | 2023 | 134 | 2.750 |
Why?
|
| ABO Blood-Group System | 10 | 2024 | 368 | 2.580 |
Why?
|
| Complement System Proteins | 9 | 2023 | 781 | 2.430 |
Why?
|
| Phosphatidylserines | 8 | 2022 | 188 | 2.390 |
Why?
|
| Galectin 4 | 5 | 2024 | 36 | 2.230 |
Why?
|
| Complement C3 | 7 | 2021 | 456 | 2.100 |
Why?
|
| Antibody Formation | 9 | 2023 | 1379 | 2.090 |
Why?
|
| Factor VIII | 5 | 2022 | 346 | 1.880 |
Why?
|
| Antigens | 7 | 2023 | 1438 | 1.810 |
Why?
|
| Anti-Infective Agents | 5 | 2024 | 972 | 1.730 |
Why?
|
| Metalloendopeptidases | 7 | 2021 | 393 | 1.680 |
Why?
|
| Membrane Glycoproteins | 10 | 2022 | 3661 | 1.600 |
Why?
|
| Hemophilia A | 5 | 2022 | 354 | 1.510 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 5 | 2023 | 147 | 1.410 |
Why?
|
| Galectin 2 | 3 | 2022 | 13 | 1.410 |
Why?
|
| Antigenic Modulation | 3 | 2021 | 11 | 1.320 |
Why?
|
| Blood Donors | 5 | 2024 | 342 | 1.290 |
Why?
|
| Kell Blood-Group System | 5 | 2020 | 22 | 1.250 |
Why?
|
| Receptors, IgG | 6 | 2020 | 566 | 1.240 |
Why?
|
| Anemia, Hemolytic | 4 | 2019 | 161 | 1.230 |
Why?
|
| Leukocytes | 7 | 2022 | 2010 | 1.190 |
Why?
|
| Antibodies | 7 | 2023 | 2406 | 1.190 |
Why?
|
| Immunity, Innate | 9 | 2022 | 3017 | 1.180 |
Why?
|
| Immunoglobulin G | 15 | 2023 | 4480 | 1.110 |
Why?
|
| B-Lymphocytes | 9 | 2021 | 4671 | 1.070 |
Why?
|
| Carbohydrates | 5 | 2023 | 387 | 1.070 |
Why?
|
| Galectin 3 | 8 | 2021 | 238 | 1.060 |
Why?
|
| Infant, Very Low Birth Weight | 5 | 2021 | 394 | 0.980 |
Why?
|
| Phagocytosis | 8 | 2022 | 1523 | 0.970 |
Why?
|
| Microarray Analysis | 4 | 2022 | 748 | 0.950 |
Why?
|
| Erythroblastosis, Fetal | 2 | 2023 | 61 | 0.930 |
Why?
|
| Platelet Transfusion | 6 | 2022 | 291 | 0.870 |
Why?
|
| Neutrophils | 9 | 2022 | 3706 | 0.860 |
Why?
|
| Antibodies, Viral | 9 | 2023 | 3074 | 0.830 |
Why?
|
| Blood Coagulation Factor Inhibitors | 1 | 2022 | 15 | 0.830 |
Why?
|
| Clodronic Acid | 1 | 2022 | 59 | 0.820 |
Why?
|
| Duffy Blood-Group System | 2 | 2021 | 55 | 0.800 |
Why?
|
| Iodoacetamide | 3 | 2022 | 33 | 0.790 |
Why?
|
| Immune System | 4 | 2023 | 801 | 0.790 |
Why?
|
| Complement Activation | 4 | 2019 | 443 | 0.790 |
Why?
|
| Glycosylation | 9 | 2023 | 1078 | 0.790 |
Why?
|
| Enterocolitis, Necrotizing | 4 | 2021 | 324 | 0.780 |
Why?
|
| Oligosaccharides | 2 | 2021 | 402 | 0.770 |
Why?
|
| HL-60 Cells | 11 | 2022 | 363 | 0.760 |
Why?
|
| Convalescence | 1 | 2021 | 103 | 0.750 |
Why?
|
| Immunity, Humoral | 4 | 2021 | 574 | 0.740 |
Why?
|
| Animals | 78 | 2023 | 166331 | 0.740 |
Why?
|
| Intestinal Mucosa | 4 | 2020 | 2987 | 0.730 |
Why?
|
| Germinal Center | 3 | 2022 | 379 | 0.710 |
Why?
|
| Infant, Premature | 6 | 2024 | 2042 | 0.700 |
Why?
|
| Blood Preservation | 4 | 2018 | 168 | 0.700 |
Why?
|
| Mice | 53 | 2023 | 80087 | 0.700 |
Why?
|
| Molecular Mimicry | 2 | 2022 | 199 | 0.670 |
Why?
|
| Mice, Inbred C57BL | 30 | 2021 | 21529 | 0.670 |
Why?
|
| Humans | 150 | 2024 | 746044 | 0.670 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2020 | 123 | 0.660 |
Why?
|
| Immunoglobulin M | 6 | 2022 | 1507 | 0.650 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2020 | 133 | 0.650 |
Why?
|
| Mice, Knockout | 22 | 2022 | 14211 | 0.650 |
Why?
|
| Blood Grouping and Crossmatching | 5 | 2020 | 101 | 0.640 |
Why?
|
| Blood Transfusion | 9 | 2023 | 1286 | 0.630 |
Why?
|
| Infant, Premature, Diseases | 3 | 2019 | 699 | 0.630 |
Why?
|
| Coronavirus | 1 | 2020 | 150 | 0.620 |
Why?
|
| Complement Pathway, Alternative | 1 | 2018 | 117 | 0.610 |
Why?
|
| Alkylation | 4 | 2022 | 84 | 0.600 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2021 | 3782 | 0.600 |
Why?
|
| Immunoglobulin A | 1 | 2021 | 967 | 0.590 |
Why?
|
| Streptococcus pneumoniae | 1 | 2023 | 718 | 0.590 |
Why?
|
| Immunization, Passive | 6 | 2021 | 612 | 0.570 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 3 | 2022 | 62 | 0.560 |
Why?
|
| Antigens, Bacterial | 2 | 2014 | 1152 | 0.550 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2022 | 1951 | 0.540 |
Why?
|
| Specimen Handling | 1 | 2020 | 694 | 0.520 |
Why?
|
| Glycomics | 2 | 2014 | 109 | 0.510 |
Why?
|
| Immune Sera | 1 | 2015 | 613 | 0.500 |
Why?
|
| Chromatography, Affinity | 3 | 2022 | 535 | 0.490 |
Why?
|
| Blood Platelets | 4 | 2020 | 2478 | 0.490 |
Why?
|
| Iron | 1 | 2022 | 1735 | 0.480 |
Why?
|
| Hypersensitivity | 1 | 2023 | 1134 | 0.470 |
Why?
|
| Protein Binding | 11 | 2024 | 9278 | 0.450 |
Why?
|
| Spleen | 6 | 2020 | 2272 | 0.450 |
Why?
|
| CD4-Positive T-Lymphocytes | 6 | 2020 | 4296 | 0.440 |
Why?
|
| Carbohydrate Sequence | 6 | 2021 | 410 | 0.440 |
Why?
|
| Immune Tolerance | 3 | 2023 | 2215 | 0.440 |
Why?
|
| Biotinylation | 6 | 2024 | 176 | 0.440 |
Why?
|
| Cytokines | 12 | 2023 | 7219 | 0.420 |
Why?
|
| Receptors, Cell Surface | 2 | 2021 | 2820 | 0.420 |
Why?
|
| Mass Spectrometry | 2 | 2022 | 2171 | 0.410 |
Why?
|
| Colitis | 2 | 2020 | 1209 | 0.410 |
Why?
|
| Biotin | 2 | 2024 | 253 | 0.400 |
Why?
|
| Colon | 1 | 2020 | 1769 | 0.400 |
Why?
|
| Galactose | 4 | 2022 | 299 | 0.400 |
Why?
|
| Apoptosis | 5 | 2022 | 9421 | 0.390 |
Why?
|
| Cell-Derived Microparticles | 1 | 2013 | 161 | 0.380 |
Why?
|
| Amino Sugars | 2 | 2008 | 39 | 0.380 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 4 | 2023 | 137 | 0.370 |
Why?
|
| Anemia | 2 | 2024 | 1481 | 0.370 |
Why?
|
| Host-Pathogen Interactions | 3 | 2014 | 1442 | 0.370 |
Why?
|
| Students, Medical | 3 | 2022 | 1872 | 0.360 |
Why?
|
| Enteropathogenic Escherichia coli | 1 | 2010 | 26 | 0.360 |
Why?
|
| Plasma Exchange | 2 | 2020 | 154 | 0.350 |
Why?
|
| N-Acetylneuraminic Acid | 2 | 2008 | 177 | 0.350 |
Why?
|
| Ligands | 6 | 2022 | 3266 | 0.350 |
Why?
|
| Ascorbic Acid | 1 | 2013 | 640 | 0.340 |
Why?
|
| Hemostatics | 2 | 2022 | 234 | 0.340 |
Why?
|
| Mice, Transgenic | 11 | 2022 | 9441 | 0.330 |
Why?
|
| Cell Survival | 11 | 2024 | 5761 | 0.320 |
Why?
|
| Adaptive Immunity | 3 | 2022 | 722 | 0.310 |
Why?
|
| Molecular Chaperones | 4 | 2020 | 736 | 0.310 |
Why?
|
| Flow Cytometry | 8 | 2022 | 5835 | 0.310 |
Why?
|
| Cell Membrane | 3 | 2021 | 3687 | 0.300 |
Why?
|
| Substrate Specificity | 4 | 2021 | 1779 | 0.300 |
Why?
|
| Cricetulus | 3 | 2022 | 817 | 0.300 |
Why?
|
| Antigen-Antibody Complex | 2 | 2022 | 512 | 0.290 |
Why?
|
| Escherichia coli Infections | 2 | 2017 | 522 | 0.290 |
Why?
|
| Protein Multimerization | 4 | 2024 | 965 | 0.290 |
Why?
|
| Models, Animal | 2 | 2013 | 2110 | 0.290 |
Why?
|
| Poly I-C | 2 | 2020 | 111 | 0.280 |
Why?
|
| CHO Cells | 3 | 2022 | 1393 | 0.280 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3055 | 0.270 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3167 | 0.260 |
Why?
|
| Cricetinae | 3 | 2022 | 2426 | 0.260 |
Why?
|
| T-Lymphocytes | 4 | 2019 | 10018 | 0.260 |
Why?
|
| Antibodies, Monoclonal | 5 | 2021 | 9105 | 0.250 |
Why?
|
| Membrane Lipids | 1 | 2006 | 252 | 0.250 |
Why?
|
| Thrombosis | 1 | 2019 | 2999 | 0.250 |
Why?
|
| Carbohydrate Conformation | 2 | 2021 | 207 | 0.250 |
Why?
|
| Fatal Outcome | 2 | 2020 | 1825 | 0.240 |
Why?
|
| Disease Models, Animal | 12 | 2022 | 17834 | 0.240 |
Why?
|
| Anemia, Neonatal | 2 | 2021 | 19 | 0.240 |
Why?
|
| Lymphocyte Depletion | 2 | 2017 | 588 | 0.240 |
Why?
|
| Female | 40 | 2024 | 382109 | 0.230 |
Why?
|
| alpha-Thalassemia | 1 | 2024 | 51 | 0.230 |
Why?
|
| Rho(D) Immune Globulin | 1 | 2023 | 34 | 0.230 |
Why?
|
| Recombinant Proteins | 7 | 2022 | 6508 | 0.220 |
Why?
|
| Multiple Myeloma | 2 | 2021 | 5101 | 0.220 |
Why?
|
| Reactive Oxygen Species | 2 | 2022 | 2070 | 0.210 |
Why?
|
| Antibodies, Neutralizing | 5 | 2023 | 1896 | 0.210 |
Why?
|
| Nucleocapsid | 1 | 2022 | 56 | 0.210 |
Why?
|
| Complement Factor H | 1 | 2023 | 108 | 0.210 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 3607 | 0.210 |
Why?
|
| Melanoma | 2 | 2020 | 5569 | 0.210 |
Why?
|
| Pandemics | 3 | 2021 | 8434 | 0.200 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2016 | 4515 | 0.200 |
Why?
|
| Internship and Residency | 1 | 2022 | 5762 | 0.200 |
Why?
|
| Sarcolemma | 1 | 2022 | 65 | 0.200 |
Why?
|
| Oligosaccharides, Branched-Chain | 1 | 2021 | 5 | 0.200 |
Why?
|
| Glycoconjugates | 1 | 2022 | 87 | 0.200 |
Why?
|
| Glycoproteins | 4 | 2023 | 2201 | 0.190 |
Why?
|
| Hemoglobin A | 2 | 2018 | 84 | 0.190 |
Why?
|
| Antigens, CD20 | 2 | 2020 | 202 | 0.190 |
Why?
|
| Blood Banks | 2 | 2019 | 106 | 0.190 |
Why?
|
| Autoantibodies | 2 | 2024 | 2044 | 0.190 |
Why?
|
| Immunologic Tests | 1 | 2022 | 102 | 0.190 |
Why?
|
| Blood Component Removal | 1 | 2022 | 123 | 0.190 |
Why?
|
| Complement C1q | 1 | 2021 | 94 | 0.190 |
Why?
|
| Interleukin-10 | 2 | 2022 | 1156 | 0.190 |
Why?
|
| Delphi Technique | 1 | 2024 | 785 | 0.190 |
Why?
|
| Nephelometry and Turbidimetry | 1 | 2020 | 90 | 0.190 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2016 | 3538 | 0.180 |
Why?
|
| Infant, Newborn | 10 | 2024 | 25752 | 0.180 |
Why?
|
| Organ Specificity | 2 | 2021 | 1949 | 0.180 |
Why?
|
| Consensus Sequence | 1 | 2021 | 372 | 0.180 |
Why?
|
| Blood Viscosity | 1 | 2020 | 126 | 0.180 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2020 | 58 | 0.180 |
Why?
|
| Photopheresis | 1 | 2020 | 33 | 0.180 |
Why?
|
| Receptor, Notch2 | 1 | 2020 | 88 | 0.180 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2023 | 2071 | 0.180 |
Why?
|
| Oxidation-Reduction | 3 | 2015 | 2183 | 0.180 |
Why?
|
| Autoimmunity | 2 | 2020 | 1332 | 0.180 |
Why?
|
| Erythropoiesis | 2 | 2021 | 681 | 0.180 |
Why?
|
| Heart Septal Defects | 1 | 2021 | 189 | 0.180 |
Why?
|
| Fluorometry | 2 | 2014 | 101 | 0.170 |
Why?
|
| Complement Inactivator Proteins | 1 | 2019 | 77 | 0.170 |
Why?
|
| Acetylglucosamine | 1 | 2021 | 187 | 0.170 |
Why?
|
| Schools, Medical | 3 | 2022 | 863 | 0.170 |
Why?
|
| Dimerization | 4 | 2008 | 886 | 0.170 |
Why?
|
| Signal Transduction | 7 | 2022 | 23112 | 0.170 |
Why?
|
| Erythrocyte Membrane | 1 | 2021 | 441 | 0.170 |
Why?
|
| Mammals | 2 | 2022 | 1126 | 0.170 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2020 | 189 | 0.170 |
Why?
|
| Escherichia coli | 3 | 2024 | 4163 | 0.170 |
Why?
|
| Serologic Tests | 1 | 2021 | 369 | 0.170 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2021 | 457 | 0.170 |
Why?
|
| Complement C5 | 1 | 2018 | 105 | 0.160 |
Why?
|
| Dendritic Cells | 3 | 2020 | 2709 | 0.160 |
Why?
|
| Receptors, Complement 3b | 1 | 2018 | 136 | 0.160 |
Why?
|
| Glucose-6-Phosphate | 1 | 2018 | 30 | 0.160 |
Why?
|
| Cross-Linking Reagents | 1 | 2021 | 690 | 0.150 |
Why?
|
| Hemoglobins | 1 | 2024 | 1510 | 0.150 |
Why?
|
| Acute Chest Syndrome | 1 | 2018 | 31 | 0.150 |
Why?
|
| Male | 31 | 2024 | 351093 | 0.150 |
Why?
|
| Immune System Diseases | 1 | 2020 | 256 | 0.150 |
Why?
|
| Amino Acid Sequence | 3 | 2021 | 13494 | 0.150 |
Why?
|
| Rh-Hr Blood-Group System | 1 | 2018 | 65 | 0.150 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 2018 | 91 | 0.150 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2023 | 613 | 0.150 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2022 | 578 | 0.150 |
Why?
|
| Interferon Type I | 2 | 2020 | 543 | 0.150 |
Why?
|
| Immunity | 1 | 2023 | 995 | 0.140 |
Why?
|
| Probability | 1 | 2022 | 2468 | 0.140 |
Why?
|
| Immunization | 2 | 2023 | 1219 | 0.140 |
Why?
|
| Histoplasma | 1 | 2016 | 39 | 0.140 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2017 | 102 | 0.140 |
Why?
|
| Galactosyltransferases | 2 | 2016 | 266 | 0.140 |
Why?
|
| Acute Disease | 2 | 2024 | 7116 | 0.140 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2021 | 2766 | 0.140 |
Why?
|
| Sensitivity and Specificity | 2 | 2022 | 14537 | 0.140 |
Why?
|
| Sequence Alignment | 1 | 2021 | 2194 | 0.140 |
Why?
|
| Calcium | 2 | 2008 | 5654 | 0.140 |
Why?
|
| Genes, X-Linked | 1 | 2016 | 128 | 0.140 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2020 | 358 | 0.130 |
Why?
|
| Neutrophil Activation | 3 | 2019 | 181 | 0.130 |
Why?
|
| Sepsis | 2 | 2022 | 2589 | 0.130 |
Why?
|
| Down Syndrome | 2 | 2021 | 879 | 0.130 |
Why?
|
| Glycolipids | 1 | 2016 | 200 | 0.130 |
Why?
|
| Career Choice | 1 | 2022 | 743 | 0.130 |
Why?
|
| Interferon-gamma | 2 | 2019 | 3133 | 0.130 |
Why?
|
| Neutrophil Infiltration | 1 | 2018 | 388 | 0.130 |
Why?
|
| Epitopes | 2 | 2014 | 2505 | 0.130 |
Why?
|
| Inflammation | 6 | 2021 | 10592 | 0.130 |
Why?
|
| Binding Sites | 2 | 2015 | 6025 | 0.130 |
Why?
|
| Muscle, Skeletal | 4 | 2022 | 4861 | 0.130 |
Why?
|
| Fluorescent Antibody Technique | 5 | 2022 | 2466 | 0.130 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2017 | 266 | 0.120 |
Why?
|
| Viper Venoms | 1 | 2014 | 14 | 0.120 |
Why?
|
| Annexin A5 | 1 | 2015 | 103 | 0.120 |
Why?
|
| Molecular Imaging | 1 | 2022 | 824 | 0.120 |
Why?
|
| Crotalid Venoms | 1 | 2014 | 29 | 0.120 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2019 | 653 | 0.120 |
Why?
|
| Desmoglein 2 | 1 | 2014 | 14 | 0.120 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2015 | 133 | 0.120 |
Why?
|
| Protein Transport | 2 | 2017 | 1960 | 0.120 |
Why?
|
| Respiratory Burst | 2 | 2022 | 108 | 0.120 |
Why?
|
| Fluorescent Dyes | 2 | 2015 | 1892 | 0.120 |
Why?
|
| Vaccination | 2 | 2023 | 3282 | 0.120 |
Why?
|
| Immunity, Mucosal | 1 | 2017 | 469 | 0.120 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2020 | 2389 | 0.110 |
Why?
|
| Blotting, Western | 2 | 2018 | 5048 | 0.110 |
Why?
|
| Carbohydrate Metabolism | 1 | 2015 | 257 | 0.110 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2018 | 235 | 0.110 |
Why?
|
| Microscopy, Confocal | 2 | 2022 | 1972 | 0.110 |
Why?
|
| Dinoprostone | 1 | 2016 | 596 | 0.110 |
Why?
|
| Protein Kinases | 1 | 2020 | 1612 | 0.110 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 2 | 2019 | 220 | 0.110 |
Why?
|
| Cell Cycle | 1 | 2022 | 2918 | 0.110 |
Why?
|
| Sulfhydryl Compounds | 1 | 2015 | 296 | 0.110 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 15308 | 0.110 |
Why?
|
| Gram-Positive Bacteria | 1 | 2014 | 178 | 0.110 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2015 | 1537 | 0.110 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2022 | 5465 | 0.110 |
Why?
|
| Cell Differentiation | 3 | 2020 | 11384 | 0.110 |
Why?
|
| Pregnancy, Animal | 1 | 2013 | 125 | 0.110 |
Why?
|
| Drug Monitoring | 1 | 2019 | 948 | 0.110 |
Why?
|
| Organ Transplantation | 2 | 2020 | 1130 | 0.110 |
Why?
|
| Dengue Virus | 1 | 2014 | 202 | 0.110 |
Why?
|
| Killer Cells, Natural | 1 | 2022 | 2170 | 0.110 |
Why?
|
| Gram-Negative Bacteria | 1 | 2014 | 264 | 0.100 |
Why?
|
| Lectins | 1 | 2014 | 480 | 0.100 |
Why?
|
| Polymorphism, Genetic | 2 | 2022 | 4275 | 0.100 |
Why?
|
| Hemostasis | 1 | 2015 | 448 | 0.100 |
Why?
|
| Cell Culture Techniques | 2 | 2022 | 1656 | 0.100 |
Why?
|
| Membrane Microdomains | 2 | 2014 | 206 | 0.100 |
Why?
|
| Immunophenotyping | 1 | 2017 | 1853 | 0.100 |
Why?
|
| Infant | 7 | 2024 | 35444 | 0.100 |
Why?
|
| Cell Separation | 1 | 2017 | 1718 | 0.100 |
Why?
|
| Forecasting | 2 | 2019 | 2905 | 0.100 |
Why?
|
| Carcinoma | 1 | 2023 | 2344 | 0.100 |
Why?
|
| Heparin | 1 | 2019 | 1631 | 0.100 |
Why?
|
| Dengue | 1 | 2014 | 256 | 0.100 |
Why?
|
| Eicosanoids | 1 | 2013 | 275 | 0.100 |
Why?
|
| Sex Characteristics | 1 | 2021 | 2558 | 0.100 |
Why?
|
| Surface Properties | 2 | 2021 | 1154 | 0.100 |
Why?
|
| Sex Factors | 3 | 2024 | 10279 | 0.090 |
Why?
|
| Membranes | 2 | 2021 | 170 | 0.090 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2009 | 495 | 0.090 |
Why?
|
| Neoplasms | 3 | 2015 | 21688 | 0.090 |
Why?
|
| Staining and Labeling | 1 | 2015 | 1091 | 0.090 |
Why?
|
| Muscle, Striated | 1 | 2010 | 17 | 0.090 |
Why?
|
| Gene Expression Regulation | 4 | 2020 | 11839 | 0.090 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2021 | 1782 | 0.090 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2019 | 1867 | 0.090 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2010 | 82 | 0.090 |
Why?
|
| Bone Marrow Transplantation | 1 | 2017 | 2676 | 0.090 |
Why?
|
| Transplantation Tolerance | 1 | 2014 | 572 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 3 | 2014 | 3784 | 0.080 |
Why?
|
| Adult | 12 | 2023 | 214958 | 0.080 |
Why?
|
| Antigens, Surface | 1 | 2013 | 1607 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2018 | 2399 | 0.080 |
Why?
|
| Lymphocyte Activation | 3 | 2015 | 5413 | 0.080 |
Why?
|
| Pathology, Clinical | 1 | 2012 | 368 | 0.080 |
Why?
|
| Gestational Age | 3 | 2024 | 3519 | 0.080 |
Why?
|
| Receptors, Immunologic | 2 | 2016 | 1415 | 0.080 |
Why?
|
| Retrospective Studies | 7 | 2022 | 78297 | 0.080 |
Why?
|
| Biocompatible Materials | 1 | 2017 | 1682 | 0.080 |
Why?
|
| Carrier Proteins | 1 | 2022 | 4926 | 0.080 |
Why?
|
| Thrombocytopenia | 1 | 2016 | 1158 | 0.080 |
Why?
|
| Statistics as Topic | 1 | 2015 | 2339 | 0.080 |
Why?
|
| Malaria | 1 | 2018 | 1200 | 0.080 |
Why?
|
| Muscular Dystrophy, Animal | 1 | 2008 | 89 | 0.080 |
Why?
|
| Cell Movement | 1 | 2020 | 5162 | 0.080 |
Why?
|
| Kidney Transplantation | 1 | 2023 | 4091 | 0.080 |
Why?
|
| Cell Line | 6 | 2023 | 15631 | 0.080 |
Why?
|
| Conization | 1 | 2007 | 18 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 2046 | 0.070 |
Why?
|
| Rabbits | 1 | 2014 | 4783 | 0.070 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2021 | 544 | 0.070 |
Why?
|
| Georgia | 2 | 2021 | 183 | 0.070 |
Why?
|
| Antigens, Differentiation | 1 | 2010 | 846 | 0.070 |
Why?
|
| Curriculum | 2 | 2019 | 3621 | 0.070 |
Why?
|
| Neovascularization, Physiologic | 1 | 2015 | 1327 | 0.070 |
Why?
|
| Nitric Oxide | 1 | 2016 | 2122 | 0.070 |
Why?
|
| Heart Diseases | 1 | 2020 | 2763 | 0.070 |
Why?
|
| Cell Death | 2 | 2014 | 1654 | 0.070 |
Why?
|
| Adolescent | 8 | 2024 | 86202 | 0.070 |
Why?
|
| Education, Medical | 1 | 2019 | 1706 | 0.070 |
Why?
|
| Dithiothreitol | 1 | 2006 | 95 | 0.070 |
Why?
|
| Acute Lung Injury | 1 | 2010 | 369 | 0.070 |
Why?
|
| Cognition | 1 | 2024 | 6773 | 0.070 |
Why?
|
| Electrocoagulation | 1 | 2007 | 157 | 0.070 |
Why?
|
| Cytosol | 1 | 2010 | 881 | 0.070 |
Why?
|
| Incidence | 3 | 2021 | 20812 | 0.070 |
Why?
|
| Cell Proliferation | 2 | 2020 | 10300 | 0.070 |
Why?
|
| Pregnancy | 5 | 2023 | 29294 | 0.070 |
Why?
|
| United States | 4 | 2022 | 70383 | 0.070 |
Why?
|
| Cell Line, Tumor | 4 | 2020 | 16657 | 0.070 |
Why?
|
| Neoplasm Staging | 1 | 2020 | 11064 | 0.070 |
Why?
|
| Child | 10 | 2024 | 78456 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2015 | 2800 | 0.060 |
Why?
|
| Heart Transplantation | 1 | 2018 | 3032 | 0.060 |
Why?
|
| Immunotherapy | 1 | 2020 | 4594 | 0.060 |
Why?
|
| Intestines | 1 | 2014 | 1892 | 0.060 |
Why?
|
| Epigenesis, Genetic | 2 | 2015 | 3655 | 0.060 |
Why?
|
| Amino Acid Substitution | 1 | 2008 | 1743 | 0.060 |
Why?
|
| Jurkat Cells | 2 | 2020 | 727 | 0.060 |
Why?
|
| Splenectomy | 2 | 2018 | 388 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 15537 | 0.060 |
Why?
|
| Disease Progression | 1 | 2020 | 13303 | 0.060 |
Why?
|
| Cells, Cultured | 3 | 2021 | 18891 | 0.060 |
Why?
|
| Cervix Uteri | 1 | 2007 | 583 | 0.060 |
Why?
|
| Benzamides | 1 | 2009 | 1341 | 0.050 |
Why?
|
| Young Adult | 6 | 2021 | 57106 | 0.050 |
Why?
|
| Time Factors | 3 | 2020 | 39587 | 0.050 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2007 | 557 | 0.050 |
Why?
|
| Barium Compounds | 1 | 2021 | 18 | 0.050 |
Why?
|
| Genotype | 3 | 2023 | 12773 | 0.050 |
Why?
|
| Antibodies, Blocking | 1 | 2022 | 231 | 0.050 |
Why?
|
| Erythrocyte Count | 1 | 2022 | 154 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2014 | 3657 | 0.050 |
Why?
|
| Photochemical Processes | 1 | 2021 | 85 | 0.050 |
Why?
|
| Child Development | 2 | 2024 | 2251 | 0.050 |
Why?
|
| Molecular Weight | 1 | 2003 | 2193 | 0.050 |
Why?
|
| Child, Preschool | 5 | 2024 | 41376 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2020 | 5688 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2022 | 216 | 0.050 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2022 | 817 | 0.050 |
Why?
|
| Asymptomatic Infections | 1 | 2021 | 130 | 0.050 |
Why?
|
| Autoimmune Diseases | 1 | 2012 | 2193 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 25177 | 0.040 |
Why?
|
| Myofibrils | 1 | 2020 | 141 | 0.040 |
Why?
|
| Fibrinogen | 1 | 2023 | 865 | 0.040 |
Why?
|
| 3' Untranslated Regions | 1 | 2022 | 520 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2008 | 2540 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 17434 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 2024 | 2206 | 0.040 |
Why?
|
| Receptors, Formyl Peptide | 1 | 2019 | 145 | 0.040 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2020 | 206 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2022 | 834 | 0.040 |
Why?
|
| Chlorides | 1 | 2021 | 666 | 0.040 |
Why?
|
| Muscle Development | 1 | 2020 | 261 | 0.040 |
Why?
|
| Transgenes | 1 | 2022 | 999 | 0.040 |
Why?
|
| Adenosine Monophosphate | 1 | 2020 | 265 | 0.040 |
Why?
|
| Protein Stability | 1 | 2020 | 563 | 0.040 |
Why?
|
| Living Donors | 1 | 2023 | 612 | 0.040 |
Why?
|
| Splanchnic Circulation | 1 | 2018 | 109 | 0.040 |
Why?
|
| Alanine | 1 | 2020 | 581 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2021 | 63661 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2020 | 15341 | 0.040 |
Why?
|
| Swine | 2 | 2023 | 5869 | 0.040 |
Why?
|
| Leukocyte Reduction Procedures | 1 | 2017 | 13 | 0.040 |
Why?
|
| Neuropeptide Y | 1 | 2018 | 189 | 0.040 |
Why?
|
| Blood Coagulation Tests | 1 | 2019 | 262 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2006 | 3722 | 0.040 |
Why?
|
| Iron Overload | 1 | 2020 | 239 | 0.040 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2021 | 312 | 0.040 |
Why?
|
| Splenomegaly | 1 | 2018 | 188 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2021 | 1809 | 0.040 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2017 | 104 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 3 | 2013 | 6095 | 0.040 |
Why?
|
| Peritoneum | 1 | 2018 | 222 | 0.040 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2017 | 104 | 0.040 |
Why?
|
| Complement C5a | 1 | 2017 | 101 | 0.040 |
Why?
|
| Polystyrenes | 1 | 2017 | 106 | 0.040 |
Why?
|
| Retinopathy of Prematurity | 1 | 2021 | 426 | 0.030 |
Why?
|
| Opsonin Proteins | 1 | 2016 | 146 | 0.030 |
Why?
|
| Caco-2 Cells | 1 | 2017 | 366 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 1 | 2021 | 844 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2021 | 2620 | 0.030 |
Why?
|
| Histoplasmosis | 1 | 2016 | 63 | 0.030 |
Why?
|
| von Willebrand Factor | 1 | 2020 | 652 | 0.030 |
Why?
|
| Middle Aged | 5 | 2021 | 214412 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2021 | 2258 | 0.030 |
Why?
|
| Glycocalyx | 1 | 2016 | 93 | 0.030 |
Why?
|
| Cell Adhesion | 2 | 2014 | 3089 | 0.030 |
Why?
|
| Multiple Organ Failure | 1 | 2018 | 387 | 0.030 |
Why?
|
| HIV Infections | 1 | 2022 | 16936 | 0.030 |
Why?
|
| Antiviral Agents | 2 | 2020 | 3012 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2016 | 747 | 0.030 |
Why?
|
| Cells, Immobilized | 1 | 2015 | 35 | 0.030 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2016 | 352 | 0.030 |
Why?
|
| Hypergammaglobulinemia | 1 | 2015 | 73 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2020 | 1148 | 0.030 |
Why?
|
| Bothrops | 1 | 2014 | 9 | 0.030 |
Why?
|
| Plant Lectins | 1 | 2015 | 102 | 0.030 |
Why?
|
| Dogs | 2 | 2010 | 3820 | 0.030 |
Why?
|
| Glycoside Hydrolases | 1 | 2015 | 135 | 0.030 |
Why?
|
| Consensus | 1 | 2024 | 3011 | 0.030 |
Why?
|
| Glass | 1 | 2015 | 115 | 0.030 |
Why?
|
| Intestine, Small | 1 | 2020 | 1186 | 0.030 |
Why?
|
| Adsorption | 1 | 2014 | 197 | 0.030 |
Why?
|